Therefore, the observed protective role of EPO against T2DM in our study may involve the suppression of miR-21 activity, thereby preventing caspase-3-mediated apoptosis of pancreatic β-cells. The gene discussed is CASP3; the disease is type 2 diabetes mellitus.